Systematic review reveals conservative therapy is feasible for grade 2 stage IA endometrial cancer, suggesting a viable path to preserve fertility.
The conservative treatment may be an option for patients with stage IA G2 EEC who desire to preserve their fertility. The immunohistochemical markers evaluation looks promising in predicting response to conservative treatment. Further large series and randomized clinical trials are needed to confirm these results.
No takes yet. Share an insight, caveat, or question.
Giampaolino et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: